Annual Grant Award Dollars

Investigator Title Sponsor ID Dates Amount
James Patrick Bridges, PhD Role of GPR116 in Alveolar Homeostasis National Institutes of Health R01 HL131634 03/18/2016 - 02/28/2021 $382,484
James Patrick Bridges, PhD Development of Salisphere-derived Systems for the Study of Cytomegalovirus vGPCR Directed Viral Growth in the Salivary Gland National Institutes of Health (University of Cincinnati) R21 DE026267 09/01/2017 - 08/31/2018 $10,383
Hitesh Deshmukh, MD, PhD Role of Commensal Bacteria in Regulating Neutrophil-mediated Host Defense in Neonates National Institutes of Health K08 HD084686 08/01/2015 - 05/31/2019 $163,037
James M Greenberg, MD Healthy Start Cincinnati Health Resources & Services Admin H49MC27823 09/01/2014 - 03/31/2019 $530,996
James M Greenberg, MD Achieving Smoking Cessation via Co-Created Neighborhood Strategies Interact for Health 2017-4-2858 12/15/2017 - 06/15/2019 $80,000
James M Greenberg, MD Infant Vitality Community Intensive Pilot Project Ohio Department of Health 03130011IV0118 04/01/2018 - 06/30/2019 $849,644
Eric S Hall, PhD Ohio Opioid Analytics Project Ohio Department of Medicaid (ODM) (Ohio State University) G-1819-05-0094 ODM2 05/14/2018 - 06/30/2019 $7,044
Margaret K Hostetter, MD Child Health Research Career Development Award (CHRCDA) Program (K12) National Institutes of Health K12 HD028827 12/07/2017 - 11/30/2022 $436,656
Alan Hall Jobe, MD, PhD Antenatal Steroid Treatment Strategies for Low Resource Countries Bill & Melinda Gates Foundation OPP1132910 10/26/2015 - 10/31/2018 $703,551
Alan Hall Jobe, MD, PhD Dosing for Antenatal Steroids - A Phase I trial in Non-Pregnant Women Bill & Melinda Gates Foundation OPP1189571 03/30/2018 - 01/31/2019 $766,477
Tatiana Viktorovna Kalin, MD, PhD Transcriptional Regulation of Cancer Progression and Metastasis by FoxM1 American Cancer Society National RSG1332501 07/01/2013 - 06/30/2017 $15,000
Tatiana Viktorovna Kalin, MD, PhD Targeting Foxm1 in Pulmonary Fibrosis National Institutes of Health R01 HL132849 09/01/2016 - 06/30/2020 $390,000
Vladimir V Kalinichenko, MD, PhD Transcriptional Regulation of Goblet Cell Metaplasia National Institutes of Health R01 HL123490 08/05/2014 - 06/30/2018 $390,000
Vladimir V Kalinichenko, MD, PhD Transcriptional Regulation of Endothelial Cells after Acute Lung Injury National Institutes of Health R01 HL141174 04/01/2018 - 03/31/2022 $524,323
Aaron Zorn, PhD
James Wells, PhD
Paul Kingma, MD, PhD		 Developmental Mechanisms of Trachea-Esophageal Birth Defects National Institutes of Health P01 HD093363 08/15/2017 - 05/31/2022 $449,928
Timothy D LeCras, PhD Biomarkers And Pathogenesis Of Lymphatic Anomalies The Lymphatic Malformation Institute Lecras, T., LMI 05/01/2017 - 04/30/2019 $162,271
Kristin R Melton, MD
Eric Kirkendall, MD		 Improving Intensive Care Medication Safety through EHR-based Algorithms. National Institutes of Health R01 LM012230 09/15/2015 - 08/31/2019 $169,874
Stephanie L Merhar, MD Early Prediction of Motor Outcomes in Neonatal Encephalopathy and Stroke National Institutes of Health (University of Cincinnati) KL2 TR001426 04/01/2017 - 03/31/2019 $162,450
Nehal A Parikh, DO Informing Developmental Screening and Evaluation Procedures for Young Infants with Complex Congenital Heart Defects American Heart Association - National (Ohio State University) AHA 60058337_Parikh 01/01/2017 - 12/31/2017 $8,223
Nehal A Parikh, DO A New Model to Identify Preterm Neonates at High-Risk for Cognitive Deficits National Institutes of Health R01 NS094200 09/01/2016 - 01/31/2021 $392,182
Nehal A Parikh, DO Early Prediction of Cerebral Palsy in Premature Infants using Advanced MRI Biomarkers National Institutes of Health R01 NS096037 09/30/2016 - 05/31/2021 $380,216
Anne Karina Perl, PhD Interstitial Resident Fibroblasts Direct Alveolar Epithelial Differentiation National Institutes of Health R01 HL131661 01/01/2017 - 11/30/2020 $466,331
Brenda Poindexter, MD, MS NICHD-2017-ABS02 Long-Term Outcomes Protocol of Premature Infants Enrolled in the NICHD-2013-ABS01 (SCAMP) Study National Institutes of Health UG1 HD027853 04/01/2016 - 03/31/2021 $320,302
Brenda Poindexter, MD, MS CAPITATION AWARD_Developmental Impact of NICU Exposures (DINE) National Institutes of Health (Albert Einstein College of Medicine) 311196 09/01/2017 - 08/31/2023 $5,000
Brenda Poindexter, MD, MS Developmental Impact of NICU Exposures (DINE) National Institutes of Health (Albert Einstein College of Medicine) 311196 09/01/2017 - 08/31/2023 $88,394
Brenda Poindexter, MD, MS Early Diagnosis of Acute Kidney Injury Using Urinary Biomarkers and Renal Oximetry in Neonates with Hypoxic Ischemic Encephalopathy National Institutes of Health (Arkansas Children's Hospital) ARCI_Poindexter 12/01/2017 - 04/30/2019 $1,625
Brenda Poindexter, MD, MS Hydrocortisone for BPD Respiratory and Developmental Outcomes Study (HYBRID Outcomes Study): Clinical Coordinating Center National Institutes of Health (Children's Hospital of Philadelphia) 3200930818 09/01/2017 - 08/31/2018 $50,919
Brenda Poindexter, MD, MS Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia National Institutes of Health (Duke University) 2034350 08/01/2017 - 07/31/2018 $3,632
Brenda Poindexter, MD, MS Safety of Sildenafil in Premature Infants at Risk of Bronchopulmonary Dysplasia Award Period 9/15/2017-9/28/2019 National Institutes of Health (Duke University) Poindexter Capitatio 09/15/2017 - 09/28/2019 $106,250
Brenda Poindexter, MD, MS NICHD-2017-ABS02 Long-Term Outcomes Protocol of Premature Infants Enrolled in the NICHD-2013-ABS01 (SCAMP) Study National Institutes of Health (Duke University) 201316 12/01/2017 - 07/31/2018 $15,200
Brenda Poindexter, MD, MS Facilitation of IRB Review for Multi-Site Clinical Research National Institutes of Health (Rochester Institute of Technology) 417196G/UR FAO GR510 09/20/2017 - 08/31/2018 $39,538
Brenda Poindexter, MD, MS High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC National Institutes of Health (The Regents of the Univ of California) U01 NS092764 09/30/2016 - 06/30/2018 $51,636
Brenda Poindexter, MD, MS High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC National Institutes of Health (The Regents of the Univ of California) U01 NS092764 07/01/2017 - 06/30/2018 $7,800
Arun Pradhan, PhD Development of FOXF1-activating Small Molecule Compound for the Treatment of Alveolar Capillary Dysplasia with Misalignment of Pulmonary Veins (ACDMPV) National Organization for Rare Disorders NORD ID 17001 04/13/2018 - 04/12/2020 $25,000
Kurt Schibler, MD Darbepoetin for Increased Red Cell Mass and Neuroprotection in Preterm Infants National Institutes of Health (University of New Mexico) 3RCR5 06/01/2017 - 05/31/2019 $56,195
Debora Ines Sinner, PhD Molecular Basis of Dorsal-ventral Patterning of the Conducting Airways National Institutes of Health R03 HL133420 09/01/2016 - 08/31/2018 $78,000
Sneha Sitaraman, Mouse model of Pediatric Interstitial Lung Disease National Institutes of Health (University of Cincinnati) P30 ES006096 04/01/2017 - 03/31/2018 $5,000
Takuji Suzuki, PhD Genome Edited iPS Cell-derived Macrophages as a Novel Lung Cell Therapy National Institutes of Health R01 HL136721 02/06/2017 - 01/31/2021 $382,200
Daniel Todd Swarr, MD The Long Non-coding RNA Fanci in Lung Development and Differentiation Francis Family Foundation Swarr MD,Daniel Todd 07/01/2016 - 06/30/2018 $54,000
Daniel Todd Swarr, MD The Role of the Long non-coding RNA Falcor in Early Endoderm and Lung Development National Institutes of Health K08 HL130666 09/01/2016 - 11/30/2020 $162,540
Bruce C Trapnell, MD RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases National Institutes of Health U54 HL127672 09/18/2014 - 07/31/2019 $625,000
Bruce C Trapnell, MD Pathogenesis-Based Diagnostics and Pharmacotherapeutics for PAP National Institutes of Health R01 HL085453 07/01/2016 - 04/30/2020 $390,000
Bruce C Trapnell, MD Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED Trial)-CC National Institutes of Health (University of Cincinnati) U01 HL131755 09/20/2016 - 06/30/2021 $62,021
Timothy E Weaver, PhD Deficiency of Phospholipid Transfer Protein, a Driver of Allergic Airway Disease National Institutes of Health R01 HL134186 08/04/2016 - 05/31/2020 $495,373
Jeffrey A Whitsett, MD
Bruce C Trapnell, MD		 Lung and Cardiovascular Development and Disease Pathogenesis Training Program National Institutes of Health T32 HL007752 07/01/2014 - 06/30/2019 $308,202
Jeffrey A Whitsett, MD
S Steven Potter, PhD		 Lung MAP Atlas Research Center National Institutes of Health U01 HL122642 06/15/2014 - 04/30/2019 $390,878
Jeffrey A Whitsett, MD Editing Alveolar Progenitor Cells for Correction of Monogenic Disease National Institutes of Health U01 HL134745 09/23/2016 - 05/31/2023 $1,286,573
Jeffrey A Whitsett, MD
Xinhua Lin, PhD		 Role of EMC3/TMEM111 in Alveolar Epithelial Cell Function National Institutes of Health R01 HL136722 04/01/2017 - 03/31/2021 $270,835
Jeffrey A Whitsett, MD Molecular Atlas of Lung Development - Data Coordinating Center National Institutes of Health (Duke University) U01 HL122638 06/15/2014 - 04/30/2019 $266,415
Yan Xu, PhD Foundational Mapping of the Neural Circuits that Control Intrinsic Lung Function Department of Health and Human Services (University of California San Diego) OT2 OD023857 02/01/2017 - 11/30/2018 $168,795
Total Annual Grant Award Dollars $13,158,393

Annual Industry Award Dollars

Investigator Industry Sponsor Amount
Vivek Narendran, MD MedImmune, Inc. $489,947
Brenda Poindexter, MD-MS GE Healthcare $44,421
Brenda Poindexter, MD-MS Mallinckrodt Pharmaceuticals $69,125
Bruce C Trapnell, MD Savara Pharmaceuticals $36,752
Total Annual Industry Award Dollars $640,245